Lecanemab could then become available on the NHS subject to approval by the National Institute for Health and Care ... needed hope,” says Katherine Gray, the head of research at the UK’s leading ...

Summary: A new study finds that brain shrinkage in Alzheimer’s patients does not follow a uniform pattern. Researchers ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative diseases.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research led by ...

New research shows that the time of day when blood samples are taken significantly impacts the levels of Alzheimer's biomarkers, including p-tau217, which is crucial for early diagnosis.

The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research.